PEMETREXED Teva liquid 100 mg/4ml flac
7680668020027
CH-66802
L01BA04
07.16.1.
Reimbursement limitations:
PEMETREXED
L’emballage à 1000 mg / 40 ml ne peut être remboursé que pour les patients …
1 / 3
google
Details
- Product number
- 6680201
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- pemetrexedum 100 mg ut pemetrexedum monohydricum, trometamolum, acidum citricum, methioninum, aqua ad iniectabile ad solutionem pro 4 ml.
Articles (1)
Pemetrexed-Teva liquid 100 mg / 4 ml, Infusionskonzentrat
Infusionskonzentrat
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
100.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 108.95
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/06/2021
Authorization holder
Teva Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 66802
- Drug name
- Pemetrexed-Teva liquid, Infusionskonzentrat
- Galenic form
- KOINF
- ATC Code
- L01BA04
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 01/09/2017
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- PEMETREXED Teva liquid 100 mg/4ml flac
- Description (DE)
- PEMETREXED Teva liquid 100 mg/4ml Durchstf
- Market launch
- 01/09/2017
- Narcotic (BTM)
- No